Publications by authors named "William H Meyer"

64Publications

Metabolic response as assessed by F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.

Authors:
Douglas J Harrison Yueh-Yun Chi Jing Tian Pooja Hingorani Leo Mascarenhas Geoffrey B McCowage Brenda J Weigel Rajkumar Venkatramani Suzanne L Wolden Torunn I Yock David A Rodeberg Andrea A Hayes-Jordan Lisa A Teot Sheri L Spunt William H Meyer Douglas S Hawkins Barry L Shulkin Marguerite T Parisi

Cancer Med 2020 Dec 19. Epub 2020 Dec 19.

Seattle Children's Hospital, Seattle, WA, USA.

View Article and Find Full Text PDF
December 2020

Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial.

Authors:
Aaron R Weiss Yen-Lin Chen Thomas J Scharschmidt Yueh-Yun Chi Jing Tian Jennifer O Black Jessica L Davis Julie C Fanburg-Smith Eduardo Zambrano James Anderson Robin Arens Odion Binitie Edwin Choy Justin W Davis Andrea Hayes-Jordan Simon C Kao Mark L Kayton Sandy Kessel Ruth Lim William H Meyer Lynn Million Scott H Okuno Andrew Ostrenga Marguerite T Parisi Daniel A Pryma R Lor Randall Mark A Rosen Mary Schlapkohl Barry L Shulkin Ethan A Smith Joel I Sorger Stephanie Terezakis Douglas S Hawkins Sheri L Spunt Dian Wang

Lancet Oncol 2020 08 20;21(8):1110-1122. Epub 2020 Jul 20.

Department of Radiation Oncology, Rush University Medical Center, Chicago, IL, USA.

View Article and Find Full Text PDF
August 2020

Improving Outcomes for Patients With Pulmonary Metastatic Ewing Sarcoma.

Authors:
William H Meyer

J Clin Oncol 2019 12 21;37(34):3173-3175. Epub 2019 Oct 21.

University of Oklahoma Health Sciences Center, Oklahoma City, OK.

View Article and Find Full Text PDF
December 2019

Maintenance chemotherapy in rhabdomyosarcoma: the new standard of care.

Authors:
William H Meyer

Lancet Oncol 2019 11 24;20(11):1476-1477. Epub 2019 Sep 24.

Jimmy Everest Section of Pediatric Hematology/Oncology, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. Electronic address:

View Article and Find Full Text PDF
November 2019

Randomized Phase II Trial of Bevacizumab or Temsirolimus in Combination With Chemotherapy for First Relapse Rhabdomyosarcoma: A Report From the Children's Oncology Group.

Authors:
Leo Mascarenhas Yueh-Yun Chi Pooja Hingorani James R Anderson Elizabeth R Lyden David A Rodeberg Daniel J Indelicato Simon C Kao Roshni Dasgupta Sheri L Spunt William H Meyer Douglas S Hawkins

J Clin Oncol 2019 11 12;37(31):2866-2874. Epub 2019 Sep 12.

University of Washington, Seattle, WA.

View Article and Find Full Text PDF
November 2019

Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group.

Authors:
Emily Hibbitts Yueh-Yun Chi Douglas S Hawkins Frederic G Barr Julie A Bradley Roshni Dasgupta William H Meyer David A Rodeberg Erin R Rudzinski Sheri L Spunt Stephen X Skapek Suzanne L Wolden Carola A S Arndt

Cancer Med 2019 10 27;8(14):6437-6448. Epub 2019 Aug 27.

Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota.

View Article and Find Full Text PDF
October 2019

Risk-based treatment for patients with first relapse or progression of rhabdomyosarcoma: A report from the Children's Oncology Group.

Authors:
Leo Mascarenhas Elizabeth R Lyden Philip P Breitfeld David O Walterhouse Sarah S Donaldson David A Rodeberg David M Parham James R Anderson William H Meyer Douglas S Hawkins

Cancer 2019 08 8;125(15):2602-2609. Epub 2019 May 8.

Department of Pediatrics, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington.

View Article and Find Full Text PDF
August 2019

Demographic and Treatment Variables Influencing Outcome for Localized Paratesticular Rhabdomyosarcoma: Results From a Pooled Analysis of North American and European Cooperative Groups.

Authors:
David O Walterhouse Donald A Barkauskas David Hall Andrea Ferrari Gian Luca De Salvo Ewa Koscielniak Michael C G Stevens Hélène Martelli Guido Seitz David A Rodeberg Margarett Shnorhavorian Roshni Dasgupta John C Breneman James R Anderson Christophe Bergeron Gianni Bisogno William H Meyer Douglas S Hawkins Veronique Minard-Colin

J Clin Oncol 2018 Oct 23:JCO2018789388. Epub 2018 Oct 23.

David O. Walterhouse, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL; Donald A. Barkauskas, University of Southern California, Los Angeles; David Hall, Children's Oncology Group, Monrovia, CA; Andrea Ferrari, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Milan; Gian Luca De Salvo, Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Padua; Gianni Bisogno, University of Padua, Padova, Italy; Ewa Koscielniak, Olgahospital, Stuttgart; Guido Seitz, University Hospital, Marburg, Germany; Michael C.G. Stevens, Royal Hospital for Children, Bristol, United Kingdom; Hélène Martelli, Assistance Publique-Hôpitaux de Paris, Hopital Bicetre, Le Kremlin-Bicetre; Christophe Bergeron, Centre Léon Bérard, Lyon; Veronique Minard-Colin, Gustave Roussy, Villejuif, France; David A. Rodeberg, East Carolina University, Greenville, NC; Margarett Shnorhavorian and Douglas S. Hawkins, Seattle Children's Hospital, University of Washington; Douglas S. Hawkins, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA; Roshni Dasgupta and John C. Breneman, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; James R. Anderson, Merck Research Laboratories, North Wales, PA; and William H. Meyer, University of Oklahoma School of Medicine, Oklahoma City, OK.

View Article and Find Full Text PDF
October 2018

The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.

Authors:
Suman Malempati Brenda J Weigel Yueh-Yun Chi Jing Tian James R Anderson David M Parham Lisa A Teot David A Rodeberg Torunn I Yock Barry L Shulkin Sheri L Spunt William H Meyer Douglas S Hawkins

Cancer 2019 01 23;125(2):290-297. Epub 2018 Oct 23.

Pediatric Hematology/Oncology, Seattle Children's Hospital, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article and Find Full Text PDF
January 2019

Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.

Authors:
Douglas S Hawkins Yueh-Yun Chi James R Anderson Jing Tian Carola A S Arndt Lisa Bomgaars Sarah S Donaldson Andrea Hayes-Jordan Leo Mascarenhas Mary Beth McCarville Jeannine S McCune Geoff McCowage Lynn Million Carol D Morris David M Parham David A Rodeberg Erin R Rudzinski Margarett Shnorhavorian Sheri L Spunt Stephen X Skapek Lisa A Teot Suzanne Wolden Torunn I Yock William H Meyer

J Clin Oncol 2018 09 9;36(27):2770-2777. Epub 2018 Aug 9.

Douglas S. Hawkins, Erin R. Rudzinski, and Margarett Shnorhavorian, Seattle Children's Hospital, Seattle, WA; Yueh-Yun Chi and Jing Tian, University of Florida, Gainesville, FL; James R. Anderson, Merck Research Laboratories, North Wales, PA; Carola A.S. Arndt, Mayo Clinic, Rochester, MN; Lisa Bomgaars, Texas Children's Hospital; Andrea Hayes-Jordan, MD Anderson Cancer Center, Houston; Stephen X. Skapek, University of Texas Southwestern, Dallas, TX; Sarah S. Donaldson, Lynn Million, and Sheri L. Spunt, Stanford University School of Medicine, Stanford; Leo Mascarenhas and David M. Parham, Children's Hospital of Los Angeles, Los Angeles; Jeannine S. McCune, City of Hope, Duarte, CA; Mary Beth McCarville, St Jude Children's Research Hospital, Memphis, TN; Geoff McCowage, Children's Hospital at Westmead, Westmead, New South Wales, Australia; Carol D. Morris, Johns Hopkins University, Baltimore, MD, David A. Rodeberg, East Carolina University, Greenville, NC; Lisa A. Teot, Boston Children's Hospital; Torunn I. Yock, Massachusetts General Hospital, Boston, MA; Suzanne Wolden, Memorial Sloan Kettering Cancer Center, New York, NY; and William H. Meyer, University of Oklahoma Health Sciences Center, Oklahoma City, OK.

View Article and Find Full Text PDF
September 2018

Consensus and controversies regarding the treatment of rhabdomyosarcoma.

Authors:
Scott C Borinstein Diana Steppan Masanori Hayashi David M Loeb Michael S Isakoff Odion Binitie Andrew S Brohl Julia A Bridge Mark Stavas Eric T Shinohara William H Meyer Damon R Reed Lars M Wagner

Pediatr Blood Cancer 2018 Feb 14;65(2). Epub 2017 Sep 14.

Division of Pediatric Hematology/Oncology, University of Kentucky, Lexington, Kentucky.

View Article and Find Full Text PDF
February 2018

Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.

Authors:
Erin R Rudzinski James R Anderson Yueh-Yun Chi Julie M Gastier-Foster Caroline Astbury Frederic G Barr Stephen X Skapek Douglas S Hawkins Brenda J Weigel Alberto Pappo William H Meyer Michael A Arnold Lisa A Teot David M Parham

Pediatr Blood Cancer 2017 Dec 18;64(12). Epub 2017 May 18.

Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, California.

View Article and Find Full Text PDF
December 2017

Diffuse Marrow Involvement in Metastatic Osteosarcoma: An Unusual Presentation.

Authors:
Suraj Pratap Hanumantha R Pokala William H Meyer Bradley C Gehrs Maria F Palacios

J Oncol Pract 2017 06 24;13(6):401-403. Epub 2017 Apr 24.

The Children's Hospital, University of Oklahoma; and College of Medicine, University of Oklahoma, Oklahoma City, OK.

View Article and Find Full Text PDF
June 2017

Patterns of chemotherapy-induced toxicities and outcome in children and adolescents with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.

Authors:
Abha A Gupta Yueh-Yun Chi James R Anderson Elizabeth Lyden Brenda Weigel Carola Arndt William H Meyer Abby Rosenberg Douglas S Hawkins

Pediatr Blood Cancer 2017 Sep 23;64(9). Epub 2017 Mar 23.

Division of Hematology/Oncology, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article and Find Full Text PDF
September 2017

Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Authors:
David O Walterhouse Alberto S Pappo Jane L Meza John C Breneman Andrea Hayes-Jordan David M Parham Timothy P Cripe James R Anderson William H Meyer Douglas S Hawkins

Cancer 2017 Jun 17;123(12):2368-2375. Epub 2017 Feb 17.

Division of Hematology/Oncology, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington.

View Article and Find Full Text PDF
June 2017

Regarding Beau.

Authors:
William H Meyer

J Clin Oncol 2016 08 6;34(22):2669-70. Epub 2016 Jun 6.

University of Oklahoma Health Sciences Center, Oklahoma City, OK.

View Article and Find Full Text PDF
August 2016

Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.

Authors:
Brenda J Weigel Elizabeth Lyden James R Anderson William H Meyer David M Parham David A Rodeberg Jeff M Michalski Douglas S Hawkins Carola A S Arndt

J Clin Oncol 2016 Jan 26;34(2):117-22. Epub 2015 Oct 26.

Brenda J. Weigel, University of Minnesota, Minneapolis; Carola A.S. Arndt, Mayo Clinic, Rochester, MN; Elizabeth Lyden, Nebraska Medical Center, Omaha, NE; James R. Anderson, Frontier Science and Technology Research Foundation, Madison, WI; William H. Meyer, University of Oklahoma Health Sciences Center, Oklahoma City, OK; David M. Parham, Children's Hospital of Los Angeles, Los Angeles, CA; David A. Rodeberg, East Carolina University, Greenville, NC; Jeff M. Michalski, Washington University School of Medicine, St Louis, MO; and Douglas S. Hawkins, University of Washington, Seattle, WA.

View Article and Find Full Text PDF
January 2016

Progress Born From a Legacy of Collaboration.

Authors:
Melissa M Hudson William H Meyer Ching-Hon Pui

J Clin Oncol 2015 Sep 24;33(27):2935-7. Epub 2015 Aug 24.

St Jude Children's Research Hospital, Memphis, TN.

View Article and Find Full Text PDF
September 2015

Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis from Four International Cooperative Groups.

Authors:
Odile Oberlin Annie Rey Kenneth L B Brown Gianni Bisogno Ewa Koscielniak Michael C G Stevens Douglas S Hawkins William H Meyer Trang H La Modesto Carli James R Anderson

Pediatr Blood Cancer 2015 Dec 10;62(12):2125-31. Epub 2015 Aug 10.

Department of Preventive and Societal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.

View Article and Find Full Text PDF
December 2015

Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Authors:
David O Walterhouse Alberto S Pappo Jane L Meza John C Breneman Andrea A Hayes-Jordan David M Parham Timothy P Cripe James R Anderson William H Meyer Douglas S Hawkins

J Clin Oncol 2014 Nov 29;32(31):3547-52. Epub 2014 Sep 29.

David O. Walterhouse, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL; Alberto S. Pappo, Saint Jude Children's Research Hospital, Memphis, TN; Jane L. Meza, James R. Anderson, University of Nebraska Medical Center College of Public Health, Omaha, NE; John C. Breneman, Children's Hospital Medical Center, Cincinnati; Timothy P. Cripe, Nationwide Children's Hospital, Columbus, OH; Andrea Hayes-Jordan, MD Anderson Cancer Center, Houston, TX; David M. Parham, William H. Meyer, University of Oklahoma School of Medicine, Oklahoma City, OK; Douglas S. Hawkins, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA.

View Article and Find Full Text PDF
November 2014